Q. Yan

Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4‐ROS‐ADAM17 pathway

Li Yang, Li Yang, Xuping Qin, 2018, Journal of cellular and molecular medicine.

Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2

Li Yang, Li Yang, S. Zeng, 2020, Mediators of inflammation.

Nox1/4 dual inhibitor GKT137831 attenuates hypertensive cardiac remodelling associating with the inhibition of ADAM17-dependent proinflammatory cytokines-induced signalling pathways in the rats with abdominal artery constriction.

S. Zeng, Hui-Qin Lu, Q. Yan, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

A Reduction in ADAM17 Expression Is Involved in the Protective Effect of the PPAR-α Activator Fenofibrate on Pressure Overload-Induced Cardiac Hypertrophy

J. Zou, S. Zeng, Hui-Qin Lu, 2018, PPAR research.

Evidence That ADAM17 Mediates the Protective Action of CGRP against Angiotensin II-Induced Inflammation in Vascular Smooth Muscle Cells

Yan Chen, Xuping Qin, S. Zeng, 2018, Mediators of inflammation.